VTRS
Viatris Inc

3,787
Mkt Cap
$13.16B
Volume
2,239.00
52W High
$13.13
52W Low
$6.85
PE Ratio
-3.74
VTRS Fundamentals
Price
$11.60
Prev Close
$11.19
Open
$11.20
50D MA
$10.45
Beta
0.78
Avg. Volume
9.54M
EPS (Annual)
-$0.5315
P/B
0.88
Rev/Employee
$459,678.13
Loading...
Loading...
News
all
press releases
Viatris To Sell Equity Stake In Biocon Biologics To Biocon For $815 Mln
(RTTNews) - Viatris Inc. (VTRS) announced that it has entered into definitive agreements with Biocon Limited for the sale of its equity stake in Biocon Biologics Limited. Under the agreements, Biocon...
Nasdaq News: Markets·5d ago
News Placeholder
More News
News Placeholder
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited PR Newswire PITTSBURGH, Dec...
PR Newswire·5d ago
News Placeholder
Viatris to Participate in Upcoming Investor Conferences
Viatris to Participate in Upcoming Investor Conferences Viatris to Participate in Upcoming Investor Conferences PR Newswire PITTSBURGH, Nov. 24, 2025 PITTSBURGH, Nov. 24, 2025 /PRNewswire/ -- Viatris...
PR Newswire·17d ago
News Placeholder
First Week of VTRS July 2026 Options Trading
Investors in Viatris Inc (Symbol: VTRS) saw new options become available this week, for the July 2026 expiration. One of the key data points that goes into the price an option buyer is willing to...
Nasdaq News: Markets·20d ago
News Placeholder
Ex-Dividend Reminder: Viatris, Radian Group and Equitable Holdings
Looking at the universe of stocks we cover at Dividend Channel, on 11/24/25, Viatris Inc (Symbol: VTRS), Radian Group, Inc. (Symbol: RDN), and Equitable Holdings Inc (Symbol: EQH) will all trade...
Nasdaq News: Markets·21d ago
News Placeholder
ANI Pharmaceuticals Stock Surges 53% YTD: Time to Buy or Sell?
ANIP's 53% YTD surge fuels strong 2025 financial performance, a raised outlook and powerful momentum in its rare disease portfolio.
Zacks·27d ago
News Placeholder
Viatris Recognized as One of the Fortune World's Best Workplaces in 2025
Viatris Recognized as One of the Fortune World's Best Workplaces in 2025 Viatris Recognized as One of the Fortune World's Best Workplaces in 2025 PR Newswire PITTSBURGH, Nov. 13, 2025 PITTSBURGH...
PR Newswire·28d ago
News Placeholder
Daily Market Wrap: Paramount Skydance, CoreWeave, and SoftBank
The market had a mixed performance on Tuesday, Nov. 11, with tech stocks underperforming as a ripple effect of Nvidia's lackluster performance. The S&P 500 was up 0.2% at the close, led by surprise...
TheStreet.com·29d ago
News Placeholder
Tuesday Sector Leaders: Healthcare, Energy
The best performing sector as of midday Tuesday is the Healthcare sector, up 1.8%. Within the sector, Viatris Inc (Symbol: VTRS) and Moderna Inc (Symbol: MRNA) are two large stocks leading the way...
Nasdaq News: Markets·30d ago
News Placeholder
Theravance's Q3 Earnings Surpass Estimates, Revenues Match
TBPH delivers a third-quarter profit, beating estimates, and 19% revenue growth, fueled by rising collaboration income from Viatris related to Yupelri sales.
Zacks·30d ago

Latest VTRS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.